 |
|
Thomas Jefferson University - John L. Wagner, M.D.
|
|
John L. Wagner, M.D.
Medical Oncology
Thomas Jefferson University
Jefferson Medical College
Department of Medical Oncology
Associate Professor
|
|
|
|
|
Mailing Address
|
1015 Walnut Street Suite 1024
Philadelphia, Pennsylvania 19107
United States
|
|
 |
|
|
Qualifications
|
B.A., Temple University, Chemistry ACS certified,
Board Certification, American Board of Internal Medicine, Internal Medicine, 2012
Board Certification, American Board of Internal Medicine, Medical Oncology, 2015
Board Certification, American Board of Internal Medicine, Hematology, 2016
|
|
|
Expertise and Research Interests
|
|
Research interest now focused on immune reconstitution post bone marrow transplant, graft manipulation and non traditional methodologies for expanding T-cells.
|
|
|
Other Expertise
|
IRB member;
Medical Director Blood and Marrow Processing Laboratory
|
|
|
Publications
|
- Lenehan PF, Gutierrez PL, Wagner JL, Milak N, Fisher GR, Ross DD. Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells. Cancer Chemotherapy and Pharmacology. 35(5): 377-86, 1995
- Wagner JL, Palti Y, DiDario DD, Faraco J. Sequence of the canine major histocompatibility complex region containing non-classical class I genes. Tissue Antigens 65: 549-555, 2005.
- Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biology of Blood and Marrow Transplantation 13: 74-82, 2007.
- Li J, Mookerjee B, Wagner J, Flomenberg N. In vitro methods for generating highly purified EBV associated tumor specific T cells by using solid phase T cell selection system for immunotherapy. Journal of Immunological Methods 328: 169-181, 2007.
- Kaulback KR, Palazzo F, WagnerJL, Lindenbaum GA, Cohen MJ. Port site metastasis of B-cell lymphoma: A first occurrence or ann under-reported complication? Surgical Laparoscopy, Endoscopy and Percutaneous Techniques 17: 554-555, 2007.
- Friedman TM, Filicko-OHara J, Mookerjee B, Wagner JL, Grosso DA, Flomenberg N, Korngold R. T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions. Biology of Blood and Marrow Transplantation 13: 1439-1447, 2007.
- Li J, Mookerjee B, Wagner J. Purification of melanoma reactive T cell by using a monocyte-based solid phase T cell selection system for adoptive therapy. Journal of Immunotherapy 31: 81-88, 2008.
- Li J, Wagner JL, Mookerjee B. Characterization of non-Conserved HLA-A*0201 binding T cell epitopes of JC virus T antigen. Virology: Research and Treatment 1: 1-9, 2008.
- Li J, Mookerjee B, Singh P, Wagner JL. Generation of BKV-specific T cells for adoptive therapy against BKV nephropathy. Virology: Research and Treatment 1: 1-11, 2008.
- Joshi A, Tang J, Kuzna M, Wagner J, Mookerjee B, Filicko J, Carabasi M, Flomenberg N, Flomenberg P. Adenovirus DNA polymerase is recognized by human CD8+ T cells. Journal of General Virology 90: 84-94, 2009.
|
|
Individual Expertise profile of
John L. Wagner, M.D., Copyright © John L. Wagner, M.D..
Last Updated
by John Wagner, M.D. : Tuesday, September 29, 2009 4:09:16 PM
|
|
|---|
|
|
|
|
|
|
|
